Mouse Anti-DTX3 Recombinant Antibody (4F10) (V2LY-0425-LY1037)

Xu, H., Liang, S., Hu, J., Liu, W., Dong, Z., & Wei, S. (2022). Deltex E3 ubiquitin ligase 3 inhibits colorectal cancer cell growth and regulates cell cycle progression via upregulating E2F transcription factor 1. Molecular Biology Reports, 49(3), 1661-1668.

Wang, S., Hao, Q., Li, J., Chen, Y., Lu, H., Wu, X., & Zhou, X. (2020). Ubiquitin ligase DTX3 empowers mutant p53 to promote ovarian cancer development. Genes & Diseases.

Ding, X. Y., Hu, H. Y., Huang, K. N., Wei, R. Q., Min, J., Qi, C., ... & Qin, X. (2020). Ubiquitination of NOTCH2 by DTX3 suppresses the proliferation and migration of human esophageal carcinoma. Cancer science, 111(2), 489-501.

Liu, J., Li, H., Mao, A., Lu, J., Liu, W., Qie, J., & Pan, G. (2020). DCAF13 promotes triple-negative breast cancer metastasis by mediating DTX3 mRNA degradation. Cell Cycle, 19(24), 3622-3631.

Chatrin, C., Gabrielsen, M., Buetow, L., Nakasone, M. A., Ahmed, S. F., Sumpton, D., ... & Huang, D. T. (2020). Structural insights into ADP-ribosylation of ubiquitin by Deltex family E3 ubiquitin ligases. Science advances, 6(38), eabc0418.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols